Lisata Therapeutics, Inc.LSTANASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank21
3Y CAGR-9.6%
5Y CAGR+1.1%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-9.6%/yr
vs +10.8%/yr prior
5Y CAGR
+1.1%/yr
Recent deceleration
Acceleration
-20.4pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $10.43M | -13.6% |
| 2024 | $12.07M | -6.9% |
| 2023 | $12.97M | -8.3% |
| 2022 | $14.14M | +23.2% |
| 2021 | $11.47M | +16.0% |
| 2020 | $9.89M | +6.4% |
| 2019 | $9.29M | -1.0% |
| 2018 | $9.39M | -20.1% |
| 2017 | $11.75M | -8.2% |
| 2016 | $12.80M | - |